Hayakawa Tomoaki, Akamatsu Nobuhisa, Kokudo Takashi, Ito Kyoji, Nishioka Yujiro, Mihara Yujiro, Ichida Akihiko, Takamoto Takeshi, Kawaguchi Yoshikuni, Hasegawa Kiyoshi
Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Transpl Int. 2025 Jul 2;38:14606. doi: 10.3389/ti.2025.14606. eCollection 2025.
Right lateral sector grafts (RLSGs) in living donor liver transplantation (LDLT) expand donor options, however, their long-term outcomes and complication rates remain unclear. We analyzed 661 LDLTs (42 RLSGs, 363 right liver grafts, 243 left liver grafts, and 13 left lateral section grafts) performed between 2000 and 2021 at the University of Tokyo Hospital. RLSG donors experienced a 4.8% major complication (Clavien-Dindo grade ≥3b) rate with no mortality. RLSG recipients had a 38.1% major complication rate and a 9.5% 90-day mortality rate. Compared with other graft types, RLSG recipients had higher rates of hepatic artery thrombosis (9.5% vs. 3.1%), portal vein stenosis (14.3% vs. 1.9%), and biliary stricture (42.9% vs. 16.3%). The 5-year survival rate for RLSG recipients (79.2%) did not differ significantly from other graft types (84.7%). Graft bile ducts measuring >4 mm were associated with increased anastomotic biliary stricture. RLSG, the only option for 33 recipients, expanded the donor pool by 5%. Although RLSG is associated with higher vascular and biliary complication rates, it demonstrates favorable long-term survival and significantly expands the donor pool. For patients without suitable conventional graft options, RLSG represents a viable choice that provides life-saving transplantation opportunities.
活体肝移植(LDLT)中的右外侧扇形移植物(RLSG)扩大了供体选择范围,然而,其长期疗效和并发症发生率仍不明确。我们分析了2000年至2021年期间在东京大学医院进行的661例LDLT(42例RLSG、363例右肝移植物、243例左肝移植物和13例左外侧段移植物)。RLSG供体的严重并发症(Clavien-Dindo分级≥3b)发生率为4.8%,无死亡病例。RLSG受者的严重并发症发生率为38.1%,90天死亡率为9.5%。与其他移植物类型相比,RLSG受者的肝动脉血栓形成率(9.5%对3.1%)、门静脉狭窄率(14.3%对1.9%)和胆管狭窄率(42.9%对16.3%)更高。RLSG受者的5年生存率(79.2%)与其他移植物类型(84.7%)相比无显著差异。直径>4 mm的移植物胆管与吻合口胆管狭窄增加有关。RLSG是33例受者的唯一选择,使供体库扩大了5%。尽管RLSG与更高的血管和胆管并发症发生率相关,但它显示出良好的长期生存率,并显著扩大了供体库。对于没有合适传统移植物选择的患者,RLSG是一种可行的选择,可提供挽救生命的移植机会。